The editors of ActiveHistory.ca are currently enjoying our annual end of summer hiatus, but we’ll be back with new content in September. During the hiatus, we’re featuring some of our most popular and favourite posts from the past year. Thanks as always to our writers and readers.
The following post was originally featured on November 24, 2016.
Women in the Atlantic Provinces have long struggled to access reproductive health care services due to the rural nature of the region. Whereas Canada’s rural population declined from 24 percent in 1971 to 19 percent in 2011, the Atlantic region’s rural population only declined from 47 percent to 46 percent rural in the same period. Christabelle Sethna and Marion Doull’s research on Canadian women’s access to freestanding abortion clinics in the 2000s demonstrates that the Atlantic Provinces have the lowest access to abortion services in the country. Many researchers argue that medical abortions would ensure access for women in the Atlantic, northern, and remote regions of Canada.
With the impending release of Mifegymiso in Canada—a prescription drug that can terminate a pregnancy in the first 49 days of gestational age—there is much debate over the requirement that women receive the drug under the supervision of a doctor. Physician-only dispensing would create an additional barrier to accessing Mifegymiso in rural areas, particularly in regions without surgical abortion services. In defence of the criticism that the federal government is limiting rural women’s access to the drug, Health Canada argues in Mifegymiso: Myths vs. Facts that medical abortions require physician oversight because approximately 1 in 20 women will require surgery for unsuccessful terminations.
The urban-rural divide surrounding access to reproductive health care services is nothing new and the role of physicians in delivering services have often been at the center of these disputes.